Acute Leukaemias Flashcards
Regardless of ?, acute leukaemias generally present with ? symptoms, ?
pain from ? infiltration, and symptoms related to ? ? failure.
subtype b bone marrow bone marrow
Symptoms;
B Symptoms: ?, ? loss, night ?, ?, fevers.
? pain.
?omegaly / ?omegaly
fatigue wt sweats pruritus bone hep splen
Symptoms related to marrow failure;
0 Anaemia: ? on ?, ?.
0 Leukopenia* : ? infections. (Although presenting with a ?, the cells are ? and nonfunctioning blast cells, thus symptoms of ? are seen.)
0 Thrombocytopenia: ? and ? (more common in ?).
sob exertion weakness recurrent leukocytosis immature leukopenia bleeeding and bruising aml
Investigations;
?.
Blood Film: ? diagnostic, with ? identified morphologically and confirmed with immunophenotyping.
CXR: ?-cell ? classically shows ? widening.
? ? aspiration: to confirm diagnosis, and confirm lineage.
? scanning to check for ? disease.
?, ? plus cardiac function testing (?/?) are then essential for ? therapy.
fbc blasts lineage t all mediastinal bm pet mets u+e, lft, ecg/echo planning
Supportive Care;
Nurse with ? ? nursing.
Insert a ? line for venous access.
Give a ?-? diet.
Frequent blood and ? ? required.
? to prevent tumour ? syndrome due to chemotherapy.
Check frequent bloods and observations for signs of ?
full barrier hickman high-calorie platelet transfusion allopurinol lysis infection
Antibiotics;
If temperature is >? degrees on ?occasions greater than an ? apart,
assume ? and start ? ? Abx until afebrile for ? hours.
o Often a ? plus ?.
38 two hour sepsis bs 72 ceph gent
ALL Management;
High dose ? to induce remission.
o Consolidation with high/medium dose ‘?’ over many weeks.
o 2 ? of maintenance therapy.
Consider a marrow ? if poor prognosis or ?.
Transplant is necessary to cure those with the ? ?
CTx blocks years transplant relapse philly chromosome
AML Management;
Intensive ?.
In disease with poor prognosis, ? marrow transplant from ?-matched ? is indicated after first-round chemotherapy.
o This then allows further ? dose ? .
In intermediate prognosis disease, ? marrow transplants may be used (cells grown from ? bone marrow).
o Further chemotherapy must be at ?doses.
CTx allogenic HLA sibling high ctx autologous own lower